Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma
NCT01524692
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Adenoid Cystic Carcinoma
Interventions
DRUG:
Dovitinib (TKI258)
Sponsor
University of Virginia
Collaborators
[object Object]